Association of brain volume loss and NEDA outcomes in patients with relapsing multiple sclerosis in the OPERA I and OPERA II studies

Author(s):  
Anthony Traboulsee
2016 ◽  
Vol 26 (5) ◽  
pp. 532-538 ◽  
Author(s):  
Angela Vidal-Jordana ◽  
Jaume Sastre-Garriga ◽  
Francisco Pérez-Miralles ◽  
Deborah Pareto ◽  
Jordi Rio ◽  
...  

2018 ◽  
Vol 90 (1) ◽  
pp. 38-43 ◽  
Author(s):  
Maria Pia Sormani ◽  
Nicola De Stefano ◽  
Gavin Giovannoni ◽  
Dawn Langdon ◽  
Daniela Piani-Meier ◽  
...  

ObjectiveTo assess the prognostic value of practice effect on Paced Auditory Serial Addition Test (PASAT) in multiple sclerosis.MethodsWe compared screening (day −14) and baseline (day 0) PASAT scores of 1009 patients from the FTY720 Research Evaluating Effects of Daily Oral therapy in Multiple Sclerosis (FREEDOMS) trial. We grouped patients into high and low learners if their PASAT score change was above or below the median change in their screening PASAT quartile group. We used Wilcoxon test to compare baseline disease characteristics between high and low learners, and multiple regression models to assess the respective impact of learning ability, baseline normalised brain volume and treatment on brain volume loss and 6-month confirmed disability progression over 2 years.ResultsThe mean PASAT score at screening was 45.38, increasing on average by 3.18 from day −14 to day 0. High learners were younger (p=0.003), had lower Expanded Disability Status Scale score (p=0.031), higher brain volume (p<0.001) and lower T2 lesion volume (p=0.009) at baseline. Learning status was not significantly associated with disability progression (HR=0.953, p=0.779), when adjusting for baseline normalised brain volume, screening PASAT score and treatment arm. However, the effect of fingolimod on disability progression was more pronounced in high learners (HR=0.396, p<0.001) than in low learners (HR=0.798, p=0.351; p for interaction=0.05). Brain volume loss at month 24 tended to be higher in low learners (0.17%, p=0.058), after adjusting for the same covariates.ConclusionsShort-term practice effects on PASAT are related to brain volume, disease severity and age and have clinically meaningful prognostic implications. High learners benefited more from fingolimod treatment.


Neurology ◽  
2018 ◽  
Vol 91 (24) ◽  
pp. 1079-1080
Author(s):  
Ruth Ann Marrie ◽  
Helmut Butzkueven ◽  
Alberto Ascherio

2015 ◽  
Vol 357 (1-2) ◽  
pp. 8-18 ◽  
Author(s):  
Timothy Vollmer ◽  
James Signorovitch ◽  
Lynn Huynh ◽  
Philip Galebach ◽  
Caroline Kelley ◽  
...  

2018 ◽  
Vol 75 (10) ◽  
pp. 1246 ◽  
Author(s):  
Magí Andorra ◽  
Kunio Nakamura ◽  
Erika J. Lampert ◽  
Irene Pulido-Valdeolivas ◽  
Irati Zubizarreta ◽  
...  

2019 ◽  
Vol 267 (2) ◽  
pp. 395-405
Author(s):  
Juichi Fujimori ◽  
Kazuo Fujihara ◽  
Ryo Ogawa ◽  
Toru Baba ◽  
Mike Wattjes ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document